HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Kenji Okada Chojiro Yamashita Masayoshi Okada Morihito Okada Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Okada, K. Articles by Okada, M. Search for Related Content PubMed PubMed Citation Articles by Okada, K. Articles by Okada, M.

Ann Thorac Surg 1995;60:1723-1728
© 1995 The Society of Thoracic Surgeons

---

Articles

Successful 24-hour reabbit heart preservation by hypothermic continuous coronary microperfusion with oxygenated university of wisconsin solution

Division II, Department of Surgery, Kobe University School of Medicine, Kobe, Japan

Accepted for publication July 28, 1995.

^* Address reprint requests to Dr K. Okada, Division II, Department of Surgery, Kobe University School of Medicine, 7-5-2 Kusunoki-cho, Chuoku, Kobe 650, Hyogo, Japan.

Background.: This study assessed whether a combination of hypothermic continuous coronary microperfusion and oxygenated University of Wisconsin Solution (UWS) improves postischemic functional recovery and minimizes myocardial tissue edema.

Methods.: Isolated rabbit hearts were divided into four groups (n = 6 each): group I (immediate reperfusion), group II (simple cold storage in UWS), group III (hypothermic continuous coronary microperfusion with UWS), and group IV (hypothermic continuous coronary microperfusion with oxygenated UWS). Hearts in groups II, III, and IV were preserved for 24 hours. Preischemic and postischemic cardiac function was measured using a Langendorff apparatus.

Results.: Hearts in group I showed complete functional recovery, whereas cardiac output in group II was inadequate. In groups III and IV, the percentage recovery rate (post/pre) and cardiac output was 57.0% ± 3.1% and 82.2% ± 9.1%, respectively (p < 0.05). In groups III and IV, perfusion pressures at the end of 24-hour preservation increased from the initial 5 mm Hg to 12.3 ± 2.7 and 8.3 ± 1.4 mm Hg (p < 0.05), respectively. In groups I, III, and IV, the percentage tissue water content was 82.8 ± 1.0, 86.7 ± 1.7, and 83.8 ± 1.6, respectively (p < 0.05 for group III versus groups I and IV). There was a significant correlation between the percentage tissue water content and coronary perfusion pressure at the end of the 24-hour preservation (r = 0.60, p = 0.040) and a significant inverse correlation between percentage tissue water content and percentage recovery rate of cardiac output (r = –0.69, p = 0.014). In ultrastructural examination, myocardial tissue edema was limited and mitochondria were well preserve in group IV.

Conclusion.: We conclude that the combination of a hypothermic continuous coronary microperfusion technique and oxygenation of UWS was the procedure of choice for reducing tissue edema and improving both the coronary microcirculation and functional recovery during 24-hour heart preservation.

This article has been cited by other articles:

				H. Abunasra, R. T. Smolenski, J. Yap, J. Jayakumar, M. Sheppard, and M. H. Yacoub Comparison of two gene transfer models for the attenuation of myocardial ischemia-reperfusion injury following preservation for cardiac transplantation Eur J Cardiothorac Surg, May 1, 2006; 29(5): 772 - 778. [Abstract] [Full Text] [PDF]

				P. Pacher, A. Nivorozhkin, and C. Szabo Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol. Rev., March 1, 2006; 58(1): 87 - 114. [Abstract] [Full Text] [PDF]

				T. P. Fitton, C. J. Barreiro, P. N. Bonde, C. Wei, F. Gage, R. Rodriguez, and J. V. Conte Attenuation of DNA Damage in Canine Hearts Preserved by Continuous Hypothermic Perfusion Ann. Thorac. Surg., November 1, 2005; 80(5): 1812 - 1820. [Abstract] [Full Text] [PDF]

				H. J. Abunasra, R. T. Smolenski, J. Yap, M. Sheppard, T. O'Brien, and M. H. Yacoub Multigene adenoviral therapy for the attenuation of ischemia-reperfusion injury after preservation for cardiac transplantation J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 998 - 1006. [Abstract] [Full Text] [PDF]

				C. Pellegrini, A. Jeppsson, C. B. Taner, T. O’Brien, V. M. Miller, H. D. Tazelaar, and C. G. A. McGregor HIGHLY EFFICIENT EX VIVO GENE TRANSFER TO THE TRANSPLANTED HEART BY MEANS OF HYPOTHERMIC PERFUSION WITH A LOW DOSE OF ADENOVIRAL VECTOR J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 493 - 500. [Abstract] [Full Text] [PDF]

				D. K. Nickless, M. Rabinov, S. M. Richards, R. A.J. Conyers, and F. L. Rosenfeldt Continuous Perfusion Improves Preservation of Donor Rat Hearts: Importance of the Implantation Phase Ann. Thorac. Surg., May 1, 1998; 65(5): 1265 - 1272. [Abstract] [Full Text] [PDF]